Zinc finger and BTB domain-containing protein 16
Zinc finger and BTB domain-containing protein 16 is a protein that in humans is encoded by the ZBTB16 gene.
Contents |
[edit] Function
This gene is a member of the Krueppel C2H2-type zinc-finger protein family and encodes a zinc finger transcription factor that contains nine Kruppel-type zinc finger domains at the carboxyl terminus. This protein is located in the nucleus, is involved in cell cycle progression, and interacts with a histone deacetylase. Specific instances of aberrant gene rearrangement at this locus have been associated with acute promyelocytic leukemia (APL)[1] and physiological roles have been identified in mouse Natural Killer T cells[2][3] and gamma-delta T cells.[4] Alternate transcriptional splice variants have been characterized in human.[5][6]
[edit] Interactions
Zinc finger and BTB domain-containing protein 16 has been shown to interact with ZBTB32,[7] Heparin-binding EGF-like growth factor,[8][9] Histone deacetylase 5,[10][11] HDAC6,[10] FHL2,[12] SIN3B,[13] Nuclear receptor co-repressor 2,[14][15][16] Angiotensin II receptor type 1,[17] HDAC1,[10][13][15] Retinoic acid receptor alpha,[18] SIN3A,[13][15][19] BCL6,[20] RUNX1T1,[21][22] HDAC4,[10][11] BMI1,[23] GATA1,[24] GATA2,[25] Promyelocytic leukemia protein[26] and Calcitriol receptor.[19][27]
[edit] See also
[edit] References
- ^ Chen, Zhu; Brand, Nigel J.; Chen, Alex; Chen, Sai-Juan; Tong, Jian-Hua; Wang, Zhen-Yi; Waxman, Samuel; Zelent, Arthur (1993). "Fusion between a novel Krüppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia". The EMBO journal 12 (3): 1161–7. PMC 413318. PMID 8384553. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=413318.
- ^ Kovalovsky, Damian; Uche, Olisambu U.; Eladad, Sonia; Hobbs, Robin M.; Yi, Woelsung; Alonzo, Eric; Chua, Kevin; Eidson, Maggie et al (2008). "The BTB-zinc finger transcriptional regulator, PLZF, controls the development of iNKT cell effector functions". Nature Immunology 9 (9): 1055–64. doi:10.1038/ni.1641. PMC 2662733. PMID 18660811. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2662733.
- ^ Savage, Adam K.; Constantinides, Michael G.; Han, Jin; Picard, Damien; Martin, Emmanuel; Li, Bofeng; Lantz, Olivier; Bendelac, Albert (2008). "The transcription factor PLZF (Zbtb16) directs the effector program of the NKT cell lineage". Immunity 29 (3): 391–403. doi:10.1016/j.immuni.2008.07.011. PMC 2613001. PMID 18703361. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2613001.
- ^ Kreslavsky, Taras; Savage, Adam K.; Hobbs, Robin; Gounari, Fotini; Bronson, Roderick; Pereira, Pablo; Pandolfi, Pier Paolo; Bendelac, Albert et al (2009). "TCR-inducible PLZF transcription factor required for innate phenotype of a subset of γδ T cells with restricted TCR diversity". Proceedings of the National Academy of Sciences of the United States of America 106 (30): 12453–8. doi:10.1073/pnas.0903895106. PMC 2718370. PMID 19617548. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2718370.
- ^ Zhang, T.; Xiong, H.; Kan, L.-X.; Zhang, C.-K.; Jiao, X.-F.; Fu, G.; Zhang, Q.-H.; Lu, L. et al (1999). "Genomic sequence, structural organization, molecular evolution, and aberrant rearrangement of promyelocytic leukemia zinc finger gene". Proceedings of the National Academy of Sciences of the United States of America 96 (20): 11422–7. doi:10.1073/pnas.96.20.11422. PMC 18049. PMID 10500192. http://www.pnas.org/content/96/20/11422.full.
- ^ "ZBTB16 zinc finger and BTB domain containing 16". Entrez. 4 October 2009. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=7704. Retrieved 10 October 2009.
- ^ Hoatlin, Maureen E.; Zhi, Yu; Ball, Helen; Silvey, Kirsten; Melnick, Ari; Stone, Stacie; Arai, Sally; Hawe, Nicola et al (1999). "A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF". Blood 94 (11): 3737–47. PMID 10572087. http://bloodjournal.hematologylibrary.org/cgi/content/full/94/11/3737.
- ^ Nanba, Daisuke; Mammoto, Akiko; Hashimoto, Koji; Higashiyama, Shigeki (2003). "Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF". The Journal of cell biology 163 (3): 489–502. doi:10.1083/jcb.200303017. PMC 2173632. PMID 14597771. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2173632.
- ^ Nanba, D; Toki, F; Higashiyama, S (2004). "Roles of charged amino acid residues in the cytoplasmic domain of proHB-EGF". Biochemical and biophysical research communications 320 (2): 376–82. doi:10.1016/j.bbrc.2004.05.176. PMID 15219838.
- ^ a b c d Chauchereau, A; Mathieu, M; De Saintignon, J; Ferreira, R; Pritchard, LL; Mishal, Z; Dejean, A; Harel-bellan, A (2004). "HDAC4 mediates transcriptional repression by the acute promyelocytic leukaemia-associated protein PLZF". Oncogene 23 (54): 8777–84. doi:10.1038/sj.onc.1208128. PMID 15467736.
- ^ a b Lemercier, C; Brocard, MP; Puvion-dutilleul, F; Kao, HY; Albagli, O; Khochbin, S (2002). "Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor". The Journal of biological chemistry 277 (24): 22045–52. doi:10.1074/jbc.M201736200. PMID 11929873.
- ^ McLoughlin, P; Ehler, E; Carlile, G; Licht, JD; Schäfer, BW (2002). "The LIM-only protein DRAL/FHL2 interacts with and is a corepressor for the promyelocytic leukemia zinc finger protein". The Journal of biological chemistry 277 (40): 37045–53. doi:10.1074/jbc.M203336200. PMID 12145280.
- ^ a b c David, G; Alland, L; Hong, SH; Wong, CW; Depinho, RA; Dejean, A (1998). "Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein". Oncogene 16 (19): 2549–56. doi:10.1038/sj.onc.1202043. PMID 9627120.
- ^ Takahashi, S; McConnell, MJ; Harigae, H; Kaku, M; Sasaki, T; Melnick, AM; Licht, JD (2004). "The Flt3 internal tandem duplication mutant inhibits the function of transcriptional repressors by blocking interactions with SMRT". Blood 103 (12): 4650–8. doi:10.1182/blood-2003-08-2759. PMID 14982881.
- ^ a b c Wong, CW; Privalsky, ML (1998). "Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6". The Journal of biological chemistry 273 (42): 27695–702. doi:10.1074/jbc.273.42.27695. PMID 9765306.
- ^ Hong, SH; David, G; Wong, CW; Dejean, A; Privalsky, ML (1997). "SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor α (RARα) and PLZF-RARα oncoproteins associated with acute promyelocytic leukemia". Proceedings of the National Academy of Sciences of the United States of America 94 (17): 9028–33. doi:10.1073/pnas.94.17.9028. PMC 23013. PMID 9256429. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=23013.
- ^ Senbonmatsu, T; Saito, T; Landon, EJ; Watanabe, O; Price Jr, E; Roberts, RL; Imboden, H; Fitzgerald, TG et al (2003). "A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy". The EMBO journal 22 (24): 6471–82. doi:10.1093/emboj/cdg637. PMC 291832. PMID 14657020. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=291832.
- ^ Martin, PJ; Delmotte, MH; Formstecher, P; Lefebvre, P (2003). "PLZF is a negative regulator of retinoic acid receptor transcriptional activity". Nuclear receptor 1 (1): 6. doi:10.1186/1478-1336-1-6. PMC 212040. PMID 14521715. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=212040.
- ^ a b Ward, JO; McConnell, MJ; Carlile, GW; Pandolfi, PP; Licht, JD; Freedman, LP (2001). "The acute promyelocytic leukemia-associated protein, promyelocytic leukemia zinc finger, regulates 1,25-dihydroxyvitamin D(3)-induced monocytic differentiation of U937 cells through a physical interaction with vitamin D(3) receptor". Blood 98 (12): 3290–300. doi:10.1182/blood.V98.12.3290. PMID 11719366.
- ^ Dhordain, P; Albagli, O; Honore, N; Guidez, F; Lantoine, D; Schmid, M; The, HD; Zelent, A et al (2000). "Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF". Oncogene 19 (54): 6240–50. doi:10.1038/sj.onc.1203976. PMID 11175338.
- ^ Melnick, AM; Westendorf, JJ; Polinger, A; Carlile, GW; Arai, S; Ball, HJ; Lutterbach, B; Hiebert, SW et al (2000). "The ETO Protein Disrupted in t(8;21)-Associated Acute Myeloid Leukemia Is a Corepressor for the Promyelocytic Leukemia Zinc Finger Protein". Molecular and cellular biology 20 (6): 2075–86. doi:10.1128/MCB.20.6.2075-2086.2000. PMC 110824. PMID 10688654. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=110824.
- ^ Melnick, A; Carlile, GW; McConnell, MJ; Polinger, A; Hiebert, SW; Licht, JD (2000). "AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein". Blood 96 (12): 3939–47. PMID 11090081.
- ^ Barna, M; Merghoub, T; Costoya, JA; Ruggero, D; Branford, M; Bergia, A; Samori, B; Pandolfi, PP (2002). "Plzf mediates transcriptional repression of HoxD gene expression through chromatin remodeling". Developmental cell 3 (4): 499–510. doi:10.1016/S1534-5807(02)00289-7. PMID 12408802.
- ^ Labbaye, C; Quaranta, MT; Pagliuca, A; Militi, S; Licht, JD; Testa, U; Peschle, C (2002). "PLZF induces megakaryocytic development, activates Tpo receptor expression and interacts with GATA1 protein". Oncogene 21 (43): 6669–79. doi:10.1038/sj.onc.1205884. PMID 12242665.
- ^ Tsuzuki, S; Enver, T (2002). "Interactions of GATA-2 with the promyelocytic leukemia zinc finger (PLZF) protein, its homologue FAZF, and the t(11;17)-generated PLZF-retinoic acid receptor alpha oncoprotein". Blood 99 (9): 3404–10. doi:10.1182/blood.V99.9.3404. PMID 11964310.
- ^ Koken, MH; Reid, A; Quignon, F; Chelbi-alix, MK; Davies, JM; Kabarowski, JH; Zhu, J; Dong, S et al (1997). "Leukemia-associated retinoic acid receptor α fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies". Proceedings of the National Academy of Sciences of the United States of America 94 (19): 10255–60. doi:10.1073/pnas.94.19.10255. PMC 23349. PMID 9294197. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=23349.
- ^ Puccetti, E; Obradovic, D; Beissert, T; Bianchini, A; Washburn, B; Chiaradonna, F; Boehrer, S; Hoelzer, D et al (2002). "AML-associated translocation products block vitamin D(3)-induced differentiation by sequestering the vitamin D(3) receptor". Cancer research 62 (23): 7050–8. PMID 12460926.
[edit] Further reading
- Chen, Z; Brand, NJ; Chen, A; Chen, SJ; Tong, JH; Wang, ZY; Waxman, S; Zelent, A (1993). "Fusion between a novel Krüppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia". The EMBO journal 12 (3): 1161–7. PMC 413318. PMID 8384553. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=413318.
- Chen, SJ; Zelent, A; Tong, JH; Yu, HQ; Wang, ZY; Derré, J; Berger, R; Waxman, S et al (1993). "Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia". The Journal of clinical investigation 91 (5): 2260–7. doi:10.1172/JCI116453. PMC 288229. PMID 8387545. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=288229.
- Reid, A; Gould, A; Brand, N; Cook, M; Strutt, P; Li, J; Licht, J; Waxman, S et al (1995). "Leukemia translocation gene, PLZF, is expressed with a speckled nuclear pattern in early hematopoietic progenitors". Blood 86 (12): 4544–52. PMID 8541544.
- Dong, S; Zhu, J; Reid, A; Strutt, P; Guidez, F; Zhong, HJ; Wang, ZY; Licht, J et al (1996). "Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein". Proceedings of the National Academy of Sciences of the United States of America 93 (8): 3624–9. doi:10.1073/pnas.93.8.3624. PMC 39661. PMID 8622986. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=39661.
- Bonaldo, MF; Lennon, G; Soares, MB (1996). "Normalization and subtraction: two approaches to facilitate gene discovery". Genome research 6 (9): 791–806. doi:10.1101/gr.6.9.791. PMID 8889548.
- Hong, SH; David, G; Wong, CW; Dejean, A; Privalsky, ML (1997). "SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor α (RARα) and PLZF-RARα oncoproteins associated with acute promyelocytic leukemia". Proceedings of the National Academy of Sciences of the United States of America 94 (17): 9028–33. doi:10.1073/pnas.94.17.9028. PMC 23013. PMID 9256429. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=23013.
- Koken, MH; Reid, A; Quignon, F; Chelbi-alix, MK; Davies, JM; Kabarowski, JH; Zhu, J; Dong, S et al (1997). "Leukemia-associated retinoic acid receptor α fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies". Proceedings of the National Academy of Sciences of the United States of America 94 (19): 10255–60. doi:10.1073/pnas.94.19.10255. PMC 23349. PMID 9294197. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=23349.
- Lin, RJ; Nagy, L; Inoue, S; Shao, W; Miller Jr, WH; Evans, RM (1998). "Role of the histone deacetylase complex in acute promyelocytic leukaemia". Nature 391 (6669): 811–4. doi:10.1038/35895. PMID 9486654.
- Guidez, F; Ivins, S; Zhu, J; Söderström, M; Waxman, S; Zelent, A (1998). "Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia". Blood 91 (8): 2634–42. PMID 9531570.
- David, G; Alland, L; Hong, SH; Wong, CW; Depinho, RA; Dejean, A (1998). "Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein". Oncogene 16 (19): 2549–56. doi:10.1038/sj.onc.1202043. PMID 9627120.
- Ahmad, KF; Engel, CK; Privé, GG (1998). "Crystal structure of the BTB domain from PLZF". Proceedings of the National Academy of Sciences of the United States of America 95 (21): 12123–8. doi:10.1073/pnas.95.21.12123. PMC 22795. PMID 9770450. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=22795.
- Van Schothorst, EM; Prins, DE; Baysal, BE; Beekman, M; Licht, JD; Waxman, S; Zelent, A; Cornelisse, CJ et al (1999). "Genomic structure of the human PLZF gene". Gene 236 (1): 21–4. doi:10.1016/S0378-1119(99)00277-2. PMID 10433962.
- Ball, HJ; Melnick, A; Shaknovich, R; Kohanski, RA; Licht, JD (1999). "The promyelocytic leukemia zinc finger (PLZF) protein binds DNA in a high molecular weight complex associated with cdc2 kinase". Nucleic Acids Research 27 (20): 4106–13. doi:10.1093/nar/27.20.4106. PMC 148680. PMID 10497277. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=148680.
- Zhang, T; Xiong, H; Kan, LX; Zhang, CK; Jiao, XF; Fu, G; Zhang, QH; Lu, L et al (1999). "Genomic sequence, structural organization, molecular evolution, and aberrant rearrangement of promyelocytic leukemia zinc finger gene". Proceedings of the National Academy of Sciences of the United States of America 96 (20): 11422–7. doi:10.1073/pnas.96.20.11422. PMC 18049. PMID 10500192. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=18049.
- Li, X; Peng, H; Schultz, DC; Lopez-guisa, JM; Rauscher Fj, 3rd; Marmorstein, R (1999). "Structure-function studies of the BTB/POZ transcriptional repression domain from the promyelocytic leukemia zinc finger oncoprotein". Cancer research 59 (20): 5275–82. PMID 10537309.
- Hoatlin, ME; Zhi, Y; Ball, H; Silvey, K; Melnick, A; Stone, S; Arai, S; Hawe, N et al (1999). "A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF". Blood 94 (11): 3737–47. PMID 10572087.
- Melnick, AM; Westendorf, JJ; Polinger, A; Carlile, GW; Arai, S; Ball, HJ; Lutterbach, B; Hiebert, SW et al (2000). "The ETO Protein Disrupted in t(8;21)-Associated Acute Myeloid Leukemia Is a Corepressor for the Promyelocytic Leukemia Zinc Finger Protein". Molecular and cellular biology 20 (6): 2075–86. doi:10.1128/MCB.20.6.2075-2086.2000. PMC 110824. PMID 10688654. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=110824.
- Hyman, J; Chen, H; Di Fiore, PP; De Camilli, P; Brunger, AT (2000). "Epsin 1 Undergoes Nucleocytosolic Shuttling and Its Eps15 Interactor Nh2-Terminal Homology (Enth) Domain, Structurally Similar to Armadillo and Heat Repeats, Interacts with the Transcription Factor Promyelocytic Leukemia Zn2+ Finger Protein (Plzf)". The Journal of cell biology 149 (3): 537–46. doi:10.1083/jcb.149.3.537. PMC 2174850. PMID 10791968. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2174850.
- Melnick, A; Carlile, GW; McConnell, MJ; Polinger, A; Hiebert, SW; Licht, JD (2000). "AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein". Blood 96 (12): 3939–47. PMID 11090081.
- He, LZ; Bhaumik, M; Tribioli, C; Rego, EM; Ivins, S; Zelent, A; Pandolfi, PP (2000). "Two critical hits for promyelocytic leukemia". Molecular cell 6 (5): 1131–41. doi:10.1016/S1097-2765(00)00111-8. PMID 11106752.
|
|||||
[edit] External links
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||